Neogenomics (NEO) Tax Provisions (2013 - 2026)
Neogenomics (NEO) reported Tax Provisions of -$472000.0 for Q1 2026, down 277.44% on a YoY basis from $266000.0 in Q1 2025, and up 81.31% quarter-over-quarter from -$2.5 million in Q4 2025.
Neogenomics (NEO) Tax Provisions (2013 - 2026) Analysis & Trends
Neogenomics has reported Tax Provisions for 14 years, with the latest figure at -$472000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 277.44% year-over-year to -$472000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.0 million (down 180.43% YoY), and the FY2025 full-year result was -$2.2 million, down 15.08% from the prior year.
- Tax Provisions for Q1 2026 stood at -$472000.0, up from -$2.5 million in the prior quarter.
- The five-year high for Tax Provisions was $740000.0 in Q3 2025, with the low at -$5.7 million in Q2 2022.
- Historically, Tax Provisions has averaged -$1.7 million across 5 years, with a median of -$960000.0 in 2023.
- Annual changes were most pronounced in 2022 — Tax Provisions sank 484.53% — and 2025, when it surged 593.33%.
- Neogenomics' Tax Provisions stood at -$2.8 million in 2022, then soared by 66.16% to -$960000.0 in 2023, then advanced by 16.25% to -$804000.0 in 2024, then slumped by 214.05% to -$2.5 million in 2025, then soared by 81.31% to -$472000.0 in 2026.
- The last three Tax Provisions figures came in at -$472000.0 (Q1 2026), -$2.5 million (Q4 2025), and $740000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -16.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 70.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 206.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 77.00 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 69.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 300,000.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 59.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 23.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 40.20 Mn |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | -472,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -472,000.00 |
| Dec 31, 2025 | -2.53 Mn |
| Sep 30, 2025 | 740,000.00 |
| Jun 30, 2025 | -724,000.00 |
| Mar 31, 2025 | 266,000.00 |
| Dec 31, 2024 | -804,000.00 |
| Sep 30, 2024 | -150,000.00 |
| Jun 30, 2024 | -375,000.00 |
| Mar 31, 2024 | -620,000.00 |
| Dec 31, 2023 | -960,000.00 |
| Sep 30, 2023 | -2.94 Mn |
| Jun 30, 2023 | -2.31 Mn |
| Mar 31, 2023 | -2.93 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -2.77 Mn |
| Jun 30, 2022 | -5.73 Mn |
| Mar 31, 2022 | -3.75 Mn |
| Dec 31, 2021 | -2.45 Mn |
| Sep 30, 2021 | -2.82 Mn |
| Jun 30, 2021 | -2.44 Mn |